US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 9.300
  • +0.220+2.42%
Close May 2 16:00 ET
  • 9.300
  • 0.0000.00%
Post 16:00 ET
644.06MMarket Cap-2.94P/E (TTM)

Bicycle Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.87%-86.37M
-171.70%-164.72M
80.13%-9.4M
-3,786.05%-39.83M
-230.89%-44.63M
-52.70%-70.87M
29.59%-60.63M
-56.02%-47.29M
82.54%-1.03M
244.90%34.1M
Net income from continuing operations
-128.72%-60.75M
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
Operating gains losses
----
--954K
--0
----
----
----
----
----
----
----
Depreciation and amortization
-1.45%1.63M
9.59%7.17M
3.02%1.7M
28.52%2.17M
-0.30%1.64M
6.49%1.66M
77.45%6.55M
19.34%1.65M
33.70%1.69M
166.61%1.65M
Deferred tax
-71.58%-1.32M
-258.08%-5.23M
-266.67%-1.03M
-145.59%-3.32M
93.02%-110K
63.58%-767K
166.44%3.31M
87.93%-282K
810.06%7.27M
-81.68%-1.58M
Other non cash items
----
-409.29%-3.23M
-692.85%-4.48M
1,038.46%1.04M
11.46%107K
1.96%104K
136.20%1.04M
809.64%755K
3.41%91K
-29.41%96K
Change In working capital
34.89%-35.54M
-143.63%-33.45M
542.06%35.93M
-97.16%921K
-123.00%-15.72M
-242.38%-54.58M
11,308.18%76.66M
-62.43%-8.13M
93.03%32.39M
3,122.64%68.34M
-Change in receivables
38.36%-9.41M
-893.93%-11.95M
426.07%19.16M
84.88%-8.3M
-111.80%-7.54M
-254.16%-15.27M
89.41%-1.2M
31.93%-5.88M
-507.14%-54.88M
543.13%63.87M
-Change in prepaid assets
64.62%-2.97M
1.35%-2.04M
25.84%3.2M
188.99%3.54M
-135.82%-393K
-383.57%-8.39M
-2.57%-2.07M
2,073.50%2.54M
-1,515.30%-3.98M
201.86%1.1M
-Change in payables and accrued expense
-16.69%-13.23M
23.01%12.79M
2,900.83%14.43M
462.69%8.34M
-90.01%1.36M
-120.91%-11.34M
-30.31%10.4M
-89.30%481K
-74.78%1.48M
89.97%13.57M
-Change in other current assets
0.37%1.09M
5.16%4.4M
0.56%1.08M
7.25%1.14M
5.45%1.1M
7.53%1.09M
55.15%4.19M
56.66%1.07M
58.04%1.06M
50.79%1.05M
-Change in other current liabilities
-15.63%-1.3M
-30.53%-4.7M
-19.17%-1.26M
-21.02%-1.19M
-64.96%-1.13M
-28.15%-1.12M
-148.96%-3.6M
-110.54%-1.06M
-101.84%-985K
-29.17%-682K
-Change in other working capital
50.26%-9.73M
-146.34%-31.95M
87.20%-677K
-102.90%-2.6M
13.63%-9.12M
-299.08%-19.56M
3,329.56%68.95M
-353.43%-5.29M
3,049.42%89.69M
-278.22%-10.55M
Cash from discontinued investing activities
Operating cash flow
-21.87%-86.37M
-171.70%-164.72M
80.13%-9.4M
-3,786.05%-39.83M
-230.89%-44.63M
-52.70%-70.87M
29.59%-60.63M
-56.02%-47.29M
82.54%-1.03M
244.90%34.1M
Investing cash flow
Cash flow from continuing investing activities
-4,933.33%-604K
57.84%-1.24M
-621.57%-368K
13.35%-435K
-51.62%-420K
99.43%-12K
84.57%-2.93M
96.48%-51K
83.18%-502K
97.17%-277K
Net PPE purchase and sale
-4,933.33%-604K
57.84%-1.24M
-621.57%-368K
13.35%-435K
-51.62%-420K
99.43%-12K
84.57%-2.93M
96.48%-51K
83.18%-502K
97.17%-277K
Cash from discontinued investing activities
Investing cash flow
-4,933.33%-604K
57.84%-1.24M
-621.57%-368K
13.35%-435K
-51.62%-420K
99.43%-12K
84.57%-2.93M
96.48%-51K
83.18%-502K
97.17%-277K
Financing cash flow
Cash flow from continuing financing activities
-102.19%-41K
107.88%519.75M
-47.41%203K
-113.61%-31.93M
4,371.25%549.61M
-31.16%1.87M
3,636.21%250.03M
-93.44%386K
147,466.67%234.63M
6,203.59%12.29M
Net issuance payments of debt
---43K
---31.91M
---42K
----
----
--0
--0
--0
----
----
Net common stock issuance
----
118.22%544.13M
--0
-100.42%-979K
4,394.98%545.11M
--0
4,272.17%249.35M
--10K
--234.49M
--12.13M
Proceeds from stock option exercised by employees
-99.89%2K
1,003.81%7.53M
-34.84%245K
556.12%912K
2,627.27%4.5M
93,450.00%1.87M
-31.04%682K
103.24%376K
-12.58%139K
-15.38%165K
Cash from discontinued financing activities
Financing cash flow
-102.19%-41K
107.88%519.75M
-47.41%203K
-113.61%-31.93M
4,371.25%549.61M
-31.16%1.87M
3,636.21%250.03M
-93.44%386K
147,466.67%234.63M
6,203.59%12.29M
Net cash flow
Beginning cash position
67.01%880.07M
55.38%526.97M
55.67%891.41M
182.56%961.91M
55.73%457.54M
55.38%526.97M
-22.69%339.15M
58.42%572.63M
-8.67%340.43M
-27.88%293.82M
Current changes in cash
-26.09%-87.02M
89.73%353.79M
79.64%-9.56M
-130.97%-72.2M
994.23%504.56M
-50.70%-69.01M
289.49%186.47M
-81.50%-46.95M
2,780.59%233.1M
239.16%46.11M
Effect of exchange rate changes
212.50%468K
-151.56%-694K
-238.17%-1.78M
287.71%1.7M
-137.87%-192K
-191.83%-416K
220.18%1.35M
-63.73%1.29M
65.32%-903K
134.56%507K
End cash Position
73.43%793.52M
67.01%880.07M
67.01%880.07M
55.67%891.41M
182.56%961.91M
55.73%457.54M
55.38%526.97M
55.38%526.97M
58.42%572.63M
-8.67%340.43M
Free cash flow
-22.70%-86.97M
-161.12%-165.96M
79.37%-9.76M
-2,537.00%-40.27M
-233.20%-45.05M
-46.12%-70.88M
39.53%-63.56M
-49.07%-47.34M
82.76%-1.53M
201.47%33.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.87%-86.37M-171.70%-164.72M80.13%-9.4M-3,786.05%-39.83M-230.89%-44.63M-52.70%-70.87M29.59%-60.63M-56.02%-47.29M82.54%-1.03M244.90%34.1M
Net income from continuing operations -128.72%-60.75M6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M
Operating gains losses ------954K--0----------------------------
Depreciation and amortization -1.45%1.63M9.59%7.17M3.02%1.7M28.52%2.17M-0.30%1.64M6.49%1.66M77.45%6.55M19.34%1.65M33.70%1.69M166.61%1.65M
Deferred tax -71.58%-1.32M-258.08%-5.23M-266.67%-1.03M-145.59%-3.32M93.02%-110K63.58%-767K166.44%3.31M87.93%-282K810.06%7.27M-81.68%-1.58M
Other non cash items -----409.29%-3.23M-692.85%-4.48M1,038.46%1.04M11.46%107K1.96%104K136.20%1.04M809.64%755K3.41%91K-29.41%96K
Change In working capital 34.89%-35.54M-143.63%-33.45M542.06%35.93M-97.16%921K-123.00%-15.72M-242.38%-54.58M11,308.18%76.66M-62.43%-8.13M93.03%32.39M3,122.64%68.34M
-Change in receivables 38.36%-9.41M-893.93%-11.95M426.07%19.16M84.88%-8.3M-111.80%-7.54M-254.16%-15.27M89.41%-1.2M31.93%-5.88M-507.14%-54.88M543.13%63.87M
-Change in prepaid assets 64.62%-2.97M1.35%-2.04M25.84%3.2M188.99%3.54M-135.82%-393K-383.57%-8.39M-2.57%-2.07M2,073.50%2.54M-1,515.30%-3.98M201.86%1.1M
-Change in payables and accrued expense -16.69%-13.23M23.01%12.79M2,900.83%14.43M462.69%8.34M-90.01%1.36M-120.91%-11.34M-30.31%10.4M-89.30%481K-74.78%1.48M89.97%13.57M
-Change in other current assets 0.37%1.09M5.16%4.4M0.56%1.08M7.25%1.14M5.45%1.1M7.53%1.09M55.15%4.19M56.66%1.07M58.04%1.06M50.79%1.05M
-Change in other current liabilities -15.63%-1.3M-30.53%-4.7M-19.17%-1.26M-21.02%-1.19M-64.96%-1.13M-28.15%-1.12M-148.96%-3.6M-110.54%-1.06M-101.84%-985K-29.17%-682K
-Change in other working capital 50.26%-9.73M-146.34%-31.95M87.20%-677K-102.90%-2.6M13.63%-9.12M-299.08%-19.56M3,329.56%68.95M-353.43%-5.29M3,049.42%89.69M-278.22%-10.55M
Cash from discontinued investing activities
Operating cash flow -21.87%-86.37M-171.70%-164.72M80.13%-9.4M-3,786.05%-39.83M-230.89%-44.63M-52.70%-70.87M29.59%-60.63M-56.02%-47.29M82.54%-1.03M244.90%34.1M
Investing cash flow
Cash flow from continuing investing activities -4,933.33%-604K57.84%-1.24M-621.57%-368K13.35%-435K-51.62%-420K99.43%-12K84.57%-2.93M96.48%-51K83.18%-502K97.17%-277K
Net PPE purchase and sale -4,933.33%-604K57.84%-1.24M-621.57%-368K13.35%-435K-51.62%-420K99.43%-12K84.57%-2.93M96.48%-51K83.18%-502K97.17%-277K
Cash from discontinued investing activities
Investing cash flow -4,933.33%-604K57.84%-1.24M-621.57%-368K13.35%-435K-51.62%-420K99.43%-12K84.57%-2.93M96.48%-51K83.18%-502K97.17%-277K
Financing cash flow
Cash flow from continuing financing activities -102.19%-41K107.88%519.75M-47.41%203K-113.61%-31.93M4,371.25%549.61M-31.16%1.87M3,636.21%250.03M-93.44%386K147,466.67%234.63M6,203.59%12.29M
Net issuance payments of debt ---43K---31.91M---42K----------0--0--0--------
Net common stock issuance ----118.22%544.13M--0-100.42%-979K4,394.98%545.11M--04,272.17%249.35M--10K--234.49M--12.13M
Proceeds from stock option exercised by employees -99.89%2K1,003.81%7.53M-34.84%245K556.12%912K2,627.27%4.5M93,450.00%1.87M-31.04%682K103.24%376K-12.58%139K-15.38%165K
Cash from discontinued financing activities
Financing cash flow -102.19%-41K107.88%519.75M-47.41%203K-113.61%-31.93M4,371.25%549.61M-31.16%1.87M3,636.21%250.03M-93.44%386K147,466.67%234.63M6,203.59%12.29M
Net cash flow
Beginning cash position 67.01%880.07M55.38%526.97M55.67%891.41M182.56%961.91M55.73%457.54M55.38%526.97M-22.69%339.15M58.42%572.63M-8.67%340.43M-27.88%293.82M
Current changes in cash -26.09%-87.02M89.73%353.79M79.64%-9.56M-130.97%-72.2M994.23%504.56M-50.70%-69.01M289.49%186.47M-81.50%-46.95M2,780.59%233.1M239.16%46.11M
Effect of exchange rate changes 212.50%468K-151.56%-694K-238.17%-1.78M287.71%1.7M-137.87%-192K-191.83%-416K220.18%1.35M-63.73%1.29M65.32%-903K134.56%507K
End cash Position 73.43%793.52M67.01%880.07M67.01%880.07M55.67%891.41M182.56%961.91M55.73%457.54M55.38%526.97M55.38%526.97M58.42%572.63M-8.67%340.43M
Free cash flow -22.70%-86.97M-161.12%-165.96M79.37%-9.76M-2,537.00%-40.27M-233.20%-45.05M-46.12%-70.88M39.53%-63.56M-49.07%-47.34M82.76%-1.53M201.47%33.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 81.620
Sample Name
Sample Code
 11.660
Sample Name
Sample Code
 6.080
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.310
5
Enerpac Tool
EPAC
41.900
Unlock Now

Discussing

BRK cash at new high: What to expect from Buffett’s meeting?
🎙️Discussion 1. Buffett said he won't sell Japanese stocks for the next ten years. What's your take? 2. In the face of market changes, do y Show More
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 125.760
Sample Name
Sample Code
 597.020
Sample Name
Sample Code
 179.280
4
Oracle
ORCL
150.730
5
ASML Holding
ASML
690.330
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.1893
Sample Name
Sample Code
 8.390
Sample Name
Sample Code
 10.970
4
Argo Blockchain
ARBK
0.4265
5
The9 Ltd
NCTY
12.300
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -